A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL)
Clinical trial NCT01804166 · COMPLETED
Trial details
- NCT number
- NCT01804166
- Sponsor
- Janssen Scientific Affairs, LLC
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-21
- Primary completion
- 2020-02-28
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.